BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32081197)

  • 21. Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells.
    Eissmann P; Watzl C
    J Immunol; 2006 Sep; 177(5):3170-7. PubMed ID: 16920955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
    Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
    Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes.
    Veillette A; Dong Z; Latour S
    Immunity; 2007 Nov; 27(5):698-710. PubMed ID: 18031694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells.
    Meazza R; Tuberosa C; Cetica V; Falco M; Loiacono F; Parolini S; Micalizzi C; Moretta A; Mingari MC; Moretta L; Bottino C; Aricò M; Pende D
    Eur J Immunol; 2014 May; 44(5):1526-34. PubMed ID: 24496997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells.
    Dong Z; Cruz-Munoz ME; Zhong MC; Chen R; Latour S; Veillette A
    Nat Immunol; 2009 Sep; 10(9):973-80. PubMed ID: 19648922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
    Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
    J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases.
    Dragovich MA; Mor A
    Autoimmun Rev; 2018 Jul; 17(7):674-682. PubMed ID: 29729453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions.
    Detre C; Keszei M; Romero X; Tsokos GC; Terhorst C
    Semin Immunopathol; 2010 Jun; 32(2):157-71. PubMed ID: 20146065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
    Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
    Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation by SLAM Family Receptors Contributes to NK Cell Mediated "Missing-Self" Recognition.
    Alari-Pahissa E; Grandclément C; Jeevan-Raj B; Leclercq G; Veillette A; Held W
    PLoS One; 2016; 11(4):e0153236. PubMed ID: 27054584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLAM Associated Protein Signaling in T Cells: Tilting the Balance Toward Autoimmunity.
    Gartshteyn Y; Askanase AD; Mor A
    Front Immunol; 2021; 12():654839. PubMed ID: 33936082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of SLAM-associated protein in the pathogenesis of autoimmune diseases and immunological disorders.
    Furukawa H; Tohma S; Kitazawa H; Komori H; Nose M; Ono M
    Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):37-44. PubMed ID: 20049647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLAM receptors and SAP influence lymphocyte interactions, development and function.
    Schwartzberg PL; Mueller KL; Qi H; Cannons JL
    Nat Rev Immunol; 2009 Jan; 9(1):39-46. PubMed ID: 19079134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant deletion of SLAM-family receptors, NKG2D and DNAM-1 reveals gene redundancy of NK cell activating receptors in NK cell development and education.
    Chen S; Dong Z
    J Leukoc Biol; 2020 Apr; 107(4):561-572. PubMed ID: 31729776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SLAM-family receptors: immune regulators with or without SAP-family adaptors.
    Veillette A
    Cold Spring Harb Perspect Biol; 2010 Mar; 2(3):a002469. PubMed ID: 20300214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical Role for SLAM/SAP Signaling in the Thymic Developmental Programming of IL-17- and IFN-γ-Producing γδ T Cells.
    Dienz O; DeVault VL; Musial SC; Mistri SK; Mei L; Baraev A; Dragon JA; Krementsov D; Veillette A; Boyson JE
    J Immunol; 2020 Mar; 204(6):1521-1534. PubMed ID: 32024701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.